Meditation may ease dialysis struggles

NCT ID NCT07620990

Symptom relief Sponsor: Cyprus Aydin University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a 4-week mindfulness meditation program can improve sleep quality, reduce stress, and ease symptoms in people receiving hemodialysis. Fifty adults on dialysis will either get meditation plus usual care or usual care alone. Researchers will measure changes using standard sleep, stress, and symptom questionnaires.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged between 18 and 75 years * Patients receiving hemodialysis treatment for at least 3 months * Patients with cognitive functions suitable for the intervention (dementia score ≥21) * Patient without hearing, vision or communication problems * Patients without a psychiatric diagnosis * Patients able to use a smartphone or tablet * Patients not participating in another study * Patients not using sleep medication or antipsychotic drugs Exclusion Criteria: * Patients younger than 18 years or older than 75 years * Patients receiving hemodialysis treatment for less than 3 months * Patients with cognitive impairment unsuitable for the intervention (dementia score ≤21) * Patient with hearing, vision or communication disabilities * Patients diagnosed with psychiatric disorders * Patients unable to use a smartphone or tablet * Patients participating in another study * Patients using sleep medication or antipsychotic drugs

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for End-stage renal disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

end stage renal failure insomnia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemodialysis Sleep quality Stress Symptom

How to take part

Only the study team decides who joins. These are the ways to reach them.

The places running it

4 sites. The list below names each one and where it is.
The official record

ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

Open the record ↗
A doctor treating you

A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Meditation may ease dialysis struggles

What the study statuses mean